A Phenome-Wide Association Study Uncovers a Pathological Role of Coagulation Factor X During Infection
Overview
Authors
Affiliations
Coagulation and inflammation are interconnected, suggesting that coagulation plays a key role in the inflammatory response to pathogens. A phenome-wide association study (PheWAS) was used to identify clinical phenotypes of patients with a polymorphism in coagulation factor X. Patients with this single nucleotide polymorphism (SNP) were more likely to be hospitalized with hemostatic and infection-related disorders, suggesting that factor X contributes to the immune response to infection. To investigate this, we modeled infections by human pathogens in a mouse model of factor X deficiency. Factor X-deficient mice were protected from systemic infection, suggesting that factor X plays a role in the immune response to Factor X deficiency was associated with reduced cytokine and chemokine production and alterations in immune cell population during infection: factor X-deficient mice demonstrated increased abundance of neutrophils, macrophages, and effector T cells. Together, these results suggest that factor X activity is associated with an inefficient immune response and contributes to the pathology of infection.
Characterization of Kunitz-Domain Anticoagulation Peptides Derived from Exotoxin Protein F6W77.
Sun F, Deng X, Gao H, Ding L, Zhu W, Luo H Toxins (Basel). 2024; 16(10).
PMID: 39453226 PMC: 11511053. DOI: 10.3390/toxins16100450.
Jerome R, Zahn L, Abner J, Joly M, Shirey-Rice J, Wallis R Transl Gastroenterol Hepatol. 2024; 9:2.
PMID: 38317753 PMC: 10838616. DOI: 10.21037/tgh-23-40.
Tomlinson B, Denham G, Torres N, Brzozowski R, Allen J, Jackson J Infect Immun. 2022; 90(10):e0037622.
PMID: 36121221 PMC: 9584223. DOI: 10.1128/iai.00376-22.
Association of genetic variations in ACE2, TIRAP and factor X with outcomes in COVID-19.
Traets M, Nijhuis R, Morre S, Ouburg S, Remijn J, Blok B PLoS One. 2022; 17(1):e0260897.
PMID: 34995294 PMC: 8740962. DOI: 10.1371/journal.pone.0260897.
Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases.
Challa A, Zaleski N, Jerome R, Lavieri R, Shirey-Rice J, Barnado A Front Genet. 2021; 12:707836.
PMID: 34394194 PMC: 8355705. DOI: 10.3389/fgene.2021.707836.